IDEXX Laboratories, Inc.

American multinational corporation

IDXX Nasdaq ISIN US45168D1046 SEC CIK 874716 LEI OGMTXK0LUU1HKV2P0J84
Follow IDEXX Laboratories Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.2B +9.9% vs same quarter last year
Net income $317.1M +15.5% vs same quarter last year
EPS, diluted $4.01 +17.9% vs same quarter last year
Operating cash flow $449.7M +11.8% vs same quarter last year
Revenue by quarter
$954.3M
$998.4M
$1.1B
$1.1B
$1.1B
$1.1B
$1.2B
$1.2B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
$0$2B$4B$6BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$4.3B$1.1B
FY24$3.9B$887.9M
FY23$3.7B$845M
FY22$3.4B$679.1M
FY21$3.2B$744.8M
FY20$2.7B$581.8M
FY19$2.4B$427.7M
FY18$2.2B$377M
FY17$2B$263.1M
FY16$1.8B$222M
FY15$1.6B$192.1M
FY14$1.5B$181.9M
FY13$1.4B$187.8M
FY12$1.3B$178.3M
FY11$1.2B$161.8M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%80%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2561.8%31.6%24.6%
FY2461%29%22.8%
FY2359.8%30%23.1%
FY2259.5%26.7%20.2%
FY2158.8%29%23.2%
FY2058%25.7%21.5%
FY1956.7%23%17.8%
FY1856.1%22.2%17%
FY1755.7%21%13.4%
FY1654.9%19.7%12.5%
FY1555.6%18.7%12%
FY1454.9%17.5%12.2%
FY1354.9%19.4%13.6%
FY1254.1%20.3%13.8%
FY1153%19.4%13.3%
Free cash flowOperating cash flow minus capital expenditure
$0$500M$1B$1.5BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$1.1B
FY24$808.1M
FY23$772.9M
FY22$394.1M
FY21$636M
FY20$541.1M
FY19$304.2M
FY18$284.3M
FY17$298.9M
FY16$274.2M
FY15$138.9M
FY14$175.3M
FY13$168.4M
FY12$164.8M
FY11$168.2M
Returned to shareholdersDividends paid and shares bought back
$0$500M$1B$1.5BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$1.2B
FY24$837M
FY23$71.9M
FY22$819.7M
FY21$746.8M
FY20$182.8M
FY19$301.7M
FY18$369.3M
FY17$282.6M
FY16$304.1M
FY15$402M
FY14$618.2M
FY13$367.8M
FY12$132.3M
FY11$255.5M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • IDEXX Laboratories
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearIDEXX LaboratoriesHealthcare median
FY2524.6%−30.6%
FY2422.8%−47%
FY2323.1%−58%
FY2220.2%−80.4%
FY2123.2%−71.9%
FY2021.5%−62.2%
FY1917.8%−46.3%
FY1817%−49.6%
FY1713.4%−45.9%
FY1612.5%−36%
FY1512%−38.4%
FY1412.2%−35.5%
FY1313.6%−37.1%
FY1213.8%−29.1%
FY1113.3%−27.9%